13 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
1 | 35155225 | An Insight on the Pathways Involved in Crizotinib and Sunitinib Induced Hepatotoxicity in HepG2 Cells and Animal Model. | 2022 | 1 |
2 | 35500680 | Necroptosis modulation by cisplatin and sunitinib in hepatocellular carcinoma cell line. | 2022 Jul 15 | 1 |
3 | 33597889 | Crizotinib and Sunitinib Induce Hepatotoxicity and Mitochondrial Apoptosis in L02 Cells via ROS and Nrf2 Signaling Pathway. | 2021 | 1 |
4 | 35153769 | Novel Compounds Synergize With Venetoclax to Target KMT2A-Rearranged Pediatric Acute Myeloid Leukemia. | 2021 | 1 |
5 | 31248045 | Heightened JNK Activation and Reduced XIAP Levels Promote TRAIL and Sunitinib-Mediated Apoptosis in Colon Cancer Models. | 2019 Jun 26 | 4 |
6 | 29435010 | Chloroquine potentiates the anticancer effect of sunitinib on renal cell carcinoma by inhibiting autophagy and inducing apoptosis. | 2018 Mar | 1 |
7 | 30109169 | Characterisation of the Morphological, Functional and Molecular Changes in Sunitinib-Resistant Renal Cell Carcinoma Cells. | 2018 | 1 |
8 | 27288242 | The tyrosine kinase inhibitor, sunitinib malate, induces cognitive impairment in vivo via dysregulating VEGFR signaling, apoptotic and autophagic machineries. | 2016 Sep | 1 |
9 | 25260394 | Hispidulin potentiates the antitumor effect of sunitinib against human renal cell carcinoma in laboratory models. | 2015 Mar | 1 |
10 | 25776476 | Cytotoxic activity of sunitinib and everolimus in Caki-1 renal cancer cells is accompanied by modulations in the expression of apoptosis-related microRNA clusters and BCL2 family genes. | 2015 Mar | 3 |
11 | 25013907 | Association of toxicity of sorafenib and sunitinib for human keratinocytes with inhibition of signal transduction and activator of transcription 3 (STAT3). | 2014 | 1 |
12 | 23471661 | Sunitinib reverse multidrug resistance in gastric cancer cells by modulating Stat3 and inhibiting P-gp function. | 2013 Nov | 2 |
13 | 20884251 | Sunitinib can enhance BCG mediated cytotoxicity to transitional cell carcinoma through apoptosis pathway. | 2012 Sep | 2 |